Celyad Oncology SA
Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC
Regulatory News:
Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a rectified notification of transparency dated September 13, 2023, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 25%, holding 7,954,808 shares i.e. 29.99% of Celyad Oncology’s shares and 27.53% voting rights as of September 4, 2023. This press release replaces the press release dated September 7, 2023.
Lesen Sie auch
Content of the Notification:
-
Reason of the Notification:
Acquisition or disposal of voting securities or voting rights
-
Notification by:
A parent undertaking or a controlling person
-
Persons subject to the notification requirement:
Fortress Investment Group LLC - 1345 Avenue of the Americas, New York, NY 10105 United States
CFIP CLYD LLC – 1345 Avenue of the Americas, New York, NY 10105 United States
CFIP CLYD (UK) Limited - 7 Clarges Street, 4th Floor, London W1J 8AE, United Kingdom
-
Date on which the threshold is crossed:
September 4, 2023
-
Threshold that is crossed (in %):
25
-
Denominator:
28,893,101
- Notified details:
A) Voting Rights |
Previous notification |
After the Transaction |
|||
|
# of voting rights |
# of voting rights |
% of voting rights |
||
Holders of voting rights |
|
Linked to the |
Not linked to the |
Linked to the |
Not linked to the |
Fortress Investment Group LLC |
0 |
0 |
0 |
0.00 % |
0.00 % |
CFIP CLYD LLC |